Our data suggest either (i) CD53+ and intrahepatic B-cell subsets represent distinct subpopulations in NASH pathophysiology or (ii) there is functional redundancy, in which other cell types drive hepatic inflammation in NASH in the absence of a full lymphocyte complement. This evidence concerns the gene CD53 and metabolic dysfunction-associated steatohepatitis.